Journal of Virology · 1991 · 188 citations · 44 references
Viral ReplicationVirus ProgenyImmunologyMolecular BiologyVirus StocksImmunotherapyViral GrowthHuman RetrovirusNf-kappa BVirus GeneViral GeneticsReplicative CapacitySp1 ElementsNeurovirologyDna ReplicationVirologyChronic Viral InfectionHivCell BiologyMolecular VirologyNatural SciencesAntiviral ResponseMedicine
Starting with a replication-incompetent molecular clone of human immunodeficiency virus type 1, lacking all the NF-kappa B and Sp1 binding sites present in the native long terminal repeat (LTR), proviruses containing reconstructed LTRs with individual or combinations of NF-kappa B and Sp1 elements were generated and evaluated for their capacity to produce virus progeny following transfection-cocultivation. Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element(s) was present in the LTR. For example, in experiments involving proviral clones with LTRs containing one or two NF-kappa B elements (and no Sp1 binding sites), a hierarchy of cellular permissivity to virus replication (peripheral blood lymphocytes = MT4 greater than H9 greater than CEM greater than Jurkat) was observed. Of note was the associated emergence of second-site LTR revertants which involved an alteration of the TATA box. These results suggest that the human immunodeficiency virus type 1 LTR possesses functional redundancy which ensures virus replication in different T-cell types and is capable of changing depending on the particular combination of transcriptional factors present.
44
DNA sequencing with chain-terminating inhibitors
Frederick Sanger, S. Nicklen, Alan Coulson · Proceedings of the National Academy of Sciences · 1977 · 69.1K citations · Full text
Dna, Engineering, Dna Analysis +20
Akio Adachi, Howard E. Gendelman, Scott Koenig et al. · Journal of Virology · 1986 · 2.9K citations · Full text
Primary Immunodeficiency, Viral Replication, Human Retrovirus +15